Hansoh Pharmaceutical Patents – Key Insights and Stats

Hansoh Pharmaceutical has a total of 12 patents globally, out of which 10 have been granted. Of these 12 patents, more than 41% patents are active. China seems to be the main focused R&D centre of Hansoh Pharmaceutical.

Hansoh Pharmaceutical was founded in the year 1995. The firm, headquartered in China is a pharmaceutical company. As of May 2023, Hansoh Pharmaceutical has a market cap of $10.51 Billion.

Do read about some of the most popular patents of Hansoh Pharmaceutical which have been covered by us in this article and also you can find Hansoh Pharmaceutical patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Hansoh Pharmaceutical patent portfolio.

How many patents does Hansoh Pharmaceutical have?

Hansoh Pharmaceutical has a total of 12 patents globally. These patents belong to 3 unique patent families. Out of 12 patents, 5 patents are active.

How Many Patents did Hansoh Pharmaceutical File Every Year?

Hansoh Pharmaceutical Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantHansoh Pharmaceutical Applications FiledHansoh Pharmaceutical Patents Granted
2022
2021
20201
20191
2018
20172
20165
20151
2014
20133
20129
2011

How many Hansoh Pharmaceutical patents are Alive/Dead?

Hansoh Pharmaceutical Patent Portfolio

How Many Patents did Hansoh Pharmaceutical File in Different Countries?

Hansoh Pharmaceutical Worldwide Patent Filing

Where are Research Centres of Hansoh Pharmaceutical Patents Located?

R&D Centres of Hansoh Pharmaceutical

List of Hansoh Pharmaceutical

Hansoh Pharma PatentsTitle
US9233954B2Organic amine salts of Azilsartan, preparation method and use thereof
EP2666773B1Organic amine salts of azilsartan, preparation method and use thereof
WO2012097697A1Organic amine salts of azilsartan, preparation method and use thereof
JP5981940B2Azilsartan organic amine salt, its preparation and use
CA2824316COrganic amine salts of azilsartan, preparation method and use thereof
AU2012208863B2Organic amine salts of azilsartan, preparation method and use thereof
BR112013017982A2Organic Amine Salt Of Azilsartan, Process Of Preparation And Use Thereof
IN311684BOrganic Amine Salts Of Azilsartan Preparation Method And Use Thereof
DE602012035007T2Organic Amines Salts Of Azilsartan, Process For Production Thereof And Their Use
RU2600986C2Azilsartan Organic Amine Salts, Method For Their Production And Use
MX340590BOrganic Amine Salts Of Azilsartan, Preparation Method And Use Thereof.
ZA201305059BOrganic Amine Salts Of Azilsartan,Preparation Method And Use Thereof

What are Hansoh Pharmaceutical‘s key innovation segments?

What Technologies are Covered by Hansoh Pharmaceutical?

The chart below distributes patents filed by Hansoh Pharmaceutical in different countries on the basis of the technology protected in patents. It also represents the markets where Hansoh Pharmaceutical thinks it’s important to protect particular technology inventions.

R&D Focus: How has Hansoh Pharmaceutical‘s search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Hansoh Pharmaceutical?

Table of Content

Insights you may find interesting

Related Articles

Computime Patents – Insights & Stats (Updated 2024)

Computime has a total of 224 patents globally, out of which 115 have been granted. Of these 224 patents, more than 63% patents are active. The United States of America is where Computime has filed the maximum number of patents, followed by Europe (EPO) and Germany. Parallelly, United States of

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.